Ginsenoside Rg1 suppressed inflammation and neuron apoptosis by activating PPARγ/HO-1 in hippocampus in rat model of cerebral ischemia-reperfusion injury

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 3, 2015, Pages 2484-2494

  Yang, Yuandong ^a   Li, Xin ^a   Zhang, Lingmin ^a   Liu, Lin ^a   Jing, Guixia ^a   Cai, Hui ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Apoptosis; Cerebral ischemia reperfusion injury; Inflammation; Ppar

Indexed keywords

GINSENOSIDE; GINSENOSIDE RG 1; HEME OXYGENASE 1; HMOX1 PROTEIN, MOUSE; MEMBRANE PROTEIN; NEUROPROTECTIVE AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL; APOPTOSIS; BRAIN ISCHEMIA; DISEASE MODEL; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; INFLAMMATION; MALE; METABOLISM; NERVE CELL; PATHOLOGY; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GINSENOSIDES; HEME OXYGENASE-1; HIPPOCAMPUS; INFLAMMATION; MALE; MEMBRANE PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 84933033783     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Livesay SL. Clinical review and implications of the guideline for the early management of patients with acute ischemic stroke. AACN Adv Crit Care 2014; 25: 130-141.
2. Zhao H, Sapolsky RM and Steinberg GK. Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats. J Cereb Blood Flow Metab 2006; 26: 1114-1121.
3. Zhou JG, Liu JC and Fang YQ. [Study on the effect of hyperbaric oxygen on apoptosis in the CA1 region of hippocampus following forebrain ischemia reperfusion]. Zhongguo Ying Yong Sheng Li Xue Za Zhi 2001; 17: 82-84.
4. Zamani M, Hassanshahi J, Soleimani M and Zamani F. Neuroprotective effect of olive oil in the hippocampus CA1 neurons following ischemia: Reperfusion in mice. J Neurosci Rural Pract 2013; 4: 164-170.
5. Justicia C, Panes J, Sole S, Cervera A, Deulofeu R, Chamorro A and Planas AM. Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats. J Cereb Blood Flow Metab 2003; 23: 1430-1440.
6. Ye XH, Wu Y, Guo PP, Wang J, Yuan SY, Shang Y and Yao SL. Lipoxin A4 analogue protects brain and reduces inflammation in a rat model of focal cerebral ischemia reperfusion. Brain Res 2010; 1323: 174-183.
7. Zhang S, Qi Y, Xu Y, Han X, Peng J, Liu K and Sun CK. Protective effect of flavonoid-rich extract from Rosa laevigata Michx on cerebral ischemia-reperfusion injury through suppression of apoptosis and inflammation. Neurochem Int 2013; 63: 522-532.
8. Wei CB, Jia JP, Liang P and Guan YQ. [Ginsenoside-Rg1 inhibits cell apoptosis induced by beta amyloid]. Zhonghua Yi Xue Za Zhi 2008; 88: 1763-1766.
9. Ma ZC, Gao Y, Wang YG, Tan HL, Xiao CR and Wang SQ. Ginsenoside Rg1 inhibits proliferation of vascular smooth muscle cells stimulated by tumor necrosis factor-alpha. Acta Pharmacol Sin 2006; 27: 1000-1006.
10. Tao T, Chen F, Bo L, Xie Q, Yi W, Zou Y, Hu B, Li J and Deng X. Ginsenoside Rg1 protects mouse liver against ischemia-reperfusion injury through anti-inflammatory and anti-apoptosis properties. J Surg Res 2014; 191: 231-238.
11. Yin H, Liu Z, Li F, Ni M, Wang B, Qiao Y, Xu X, Zhang M, Zhang J, Lu H and Zhang Y. Ginsenoside-Rg1 enhances angiogenesis and ameliorates ventricular remodeling in a rat model of myocardial infarction. J Mol Med (Berl) 2011; 89: 363-375.
12. Aleshin S, Strokin M, Sergeeva M and Reiser G. Peroxisome proliferator-activated receptor (PPAR)beta/delta, a possible nexus of PPARalpha- and PPARgamma-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses. Neurochem Int 2013; 63: 322-330.
13. Klotz L, Diehl L, Dani I, Neumann H, von Oppen N, Dolf A, Endl E, Klockgether T, Engelhardt B and Knolle P. Brain endothelial PPARgamma controls inflammation-induced CD4+ T cell adhesion and transmigration in vitro. J Neuroimmunol 2007; 190: 34-43.
14. Ishibashi Y, Matsui T, Ohta K, Tanoue R, Takeuchi M, Asanuma K, Fukami K, Okuda S, Nakamura K and Yamagishi S. PEDF inhibits AGE-induced podocyte apoptosis via PPAR-gamma activation. Microvasc Res 2013; 85: 54-58.
15. Park SY, Bae JU, Hong KW and Kim CD. HO-1 Induced by Cilostazol Protects Against TNF-alpha-associated Cytotoxicity via a PPAR-gamma-dependent Pathway in Human Endothelial Cells. Korean J Physiol Pharmacol 2011; 15: 83-88.
16. Li YX, Li G, Dong WP, Lu DR and Tan JM. Protection of human islets from induction of apoptosis and improved islet function with HO-1 gene transduction. Chin Med J (Engl) 2006; 119: 1639-1645.
17. Carter EP, Garat C and Imamura M. Continual emerging roles of HO-1: protection against airway inflammation. Am J Physiol Lung Cell Mol Physiol 2004; 287: L24-25.
18. Sato T, Hanyu H, Hirao K, Kanetaka H, Sakurai H and Iwamoto T. Efficacy of PPAR-gamma agonist pioglitazone in mild Alzheimer disease. Neurobiol Aging 2011; 32: 1626-1633.
19. Luan H, Kan Z, Xu Y, Lv C and Jiang W. Rosmarinic acid protects against experimental diabetes with cerebral ischemia: relation to inflammation response. J Neuroinflammation 2013; 10: 28.
20. Ren M, Senatorov VV, Chen RW and Chuang DM. Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model. Proc Natl Acad Sci U S A 2003; 100: 6210-6215.
21. Efrati S, Berman S, Ilgiyeav E, Averbukh Z and Weissgarten J. PPAR-gamma activation inhibits angiotensin II synthesis, apoptosis, and proliferation of mesangial cells from spontaneously hypertensive rats. Nephron Exp Nephrol 2007; 106: e107-112.
22. Bernardo A and Minghetti L. PPAR-gamma agonists as regulators of microglial activation and brain inflammation. Curr Pharm Des 2006; 12: 93-109.
23. Kronke G, Kadl A, Ikonomu E, Bluml S, Furnkranz A, Sarembock IJ, Bochkov VN, Exner M, Binder BR and Leitinger N. Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors. Arterioscler Thromb Vasc Biol 2007; 27: 1276-1282.
24. Cai C, Teng L, Vu D, He JQ, Guo Y, Li Q, Tang XL, Rokosh G, Bhatnagar A and Bolli R. The heme oxygenase 1 inducer (CoPP) protects human cardiac stem cells against apoptosis through activation of the extracellular signal-regulated kinase (ERK)/NRF2 signaling pathway and cytokine release. J Biol Chem 2012; 287: 33720-33732.
25. Lang D, Reuter S, Buzescu T, August C and Heidenreich S. Heme-induced heme oxygenase-1 (HO-1) in human monocytes inhibits apoptosis despite caspase-3 up-regulation. Int Immunol 2005; 17: 155-165.
26. Lin H, Yu CH, Jen CY, Cheng CF, Chou Y, Chang CC and Juan SH. Adiponectin-mediated heme oxygenase-1 induction protects against iron-induced liver injury via a PPARalpha dependent mechanism. Am J Pathol 2010; 177: 1697-1709.
27. Bindu S, Pal C, Dey S, Goyal M, Alam A, Iqbal MS, Dutta S, Sarkar S, Kumar R, Maity P and Bandyopadhyay U. Translocation of heme oxygenase-1 to mitochondria is a novel cytoprotective mechanism against non-steroidal anti-inflammatory drug-induced mitochondrial oxidative stress, apoptosis, and gastric mucosal injury. J Biol Chem 2011; 286: 39387-39402.
28. Liou KT, Shen YC, Chen CF, Tsao CM and Tsai SK. Honokiol protects rat brain from focal cerebral ischemia-reperfusion injury by inhibiting neutrophil infiltration and reactive oxygen species production. Brain Res 2003; 992: 159-166.
29. Zeng L, Wang Y, Liu J, Wang L, Weng S, Chen K, Domino EF and Yang GY. Pro-inflammatory cytokine network in peripheral inflammation response to cerebral ischemia. Neurosci Lett 2013; 548: 4-9.
30. Kaundal RK and Sharma SS. GW1929: a nonthiazolidinedione PPARgamma agonist, ameliorates neurological damage in global cerebral ischemic-reperfusion injury through reduction in inflammation and DNA fragmentation. Behav Brain Res 2011; 216: 606-612.
31. Asavarut P, Zhao H, Gu J and Ma D. The role of HMGB1 in inflammation-mediated organ injury. Acta Anaesthesiol Taiwan 2013; 51: 28-33.
32. Buhimschi CS, Baumbusch MA, Dulay AT, Oliver EA, Lee S, Zhao G, Bhandari V, Ehrenkranz RA, Weiner CP, Madri JA and Buhimschi IA. Characterization of RAGE, HMGB1, and S100beta in inflammation-induced preterm birth and fetal tissue injury. Am J Pathol 2009; 175: 958-975.
33. Ito Y, Bhawal UK, Sasahira T, Toyama T, Sato T, Matsuda D, Nishikiori H, Kobayashi M, Sugiyama M, Hamada N, Arakawa H and Kuniyasu H. Involvement of HMGB1 and RAGE in IL-1beta-induced gingival inflammation. Arch Oral Biol 2012; 57: 73-80.
34. Wu X, Mi Y, Yang H, Hu A, Zhang Q and Shang C. The activation of HMGB1 as a progression factor on inflammation response in normal human bronchial epithelial cells through RAGE/JNK/NF-kappaB pathway. Mol Cell Biochem 2013; 380: 249-257.
35. Hu JF, Song XY, Chu SF, Chen J, Ji HJ, Chen XY, Yuan YH, Han N, Zhang JT and Chen NH. Inhibitory effect of ginsenoside Rg1 on lipopolysaccharide-induced microglial activation in mice. Brain Res 2011; 1374: 8-14.